Numerous studies have indicated that inactivation of p53 is one of the essential requirements for the unrestrained growth of tumoral cells. When the status of the p53 gene was examined in various types of lymphoid malignancies, mutations in p53 have been predominantly detected in Burkitt's lymphoma (BL) cells, therefore suggesting that alteration of p53 could speci®cally contribute to the malignant phenotype of these tumoral cells. In addition to mutations, functional inactivation of p53 can also occur through interaction of the wild-type gene product with various viral or cellular proteins. The cellular MDM2 protein, for example, is able to inhibit p53 tumor suppressor function by concealing its transactivation domain. Mdm2 gene ampli®cation has been described in several types of sarcomas, resulting in overexpression of the MDM2 protein. In this study, we have examined the status of MDM2 and p53 in 20 BL cell lines. Four were found to contain wild-type p53 and to overexpress MDM2 protein. Within these BL cells, both molecules are physically associated since they can be co-precipitated and p53 is inactivated as cells neither arrest in G1 nor enter apoptosis following g-radiation. We also report that the high level of the MDM2 protein in BL cells is neither associated with an ampli®cation of the mdm2 gene nor with an elevated level of RNA or an increased protein stability, but is rather due to an enhanced translation ability of the mdm2 RNA. These results indicate that in certain BL cells, overexpression of MDM2 protein regulated at the posttranscriptional level, induces an escape from p53-controlled cell growth.
Introduction
Burkitt's lymphoma (BL) is a monoclonal B-cell tumor which is the commonest childhood cancer in certain parts of equatorial Africa and Papua New Guinea. A second form of the disease also occurs world wide but at much lower incidence. All BL cells, regardless of their geographical origin, display speci®c chromosomal translocations leading to the juxtaposition of the c-myc proto-oncogene with either the heavy chain immunoglobulin gene t(8;14) or the light chain immunoglobulin genes t(2;8) or t(8;22). These lesions result in deregulation and activation of c-myc but the amount of the c-myc protein is, in general, not markedly enhanced in BL cells. Histologically, the two forms of BL are also identical but they dier in their association with Epstein ± Barr virus (EBV), a human herpes virus. 95% of BL from endemic areas carry the virus, whereas only 10 ± 20% of the sporadic BL are EBV(+) (reviewed in Magrath, 1990; Bornkamm et al., 1988) . These features have established Burkitt's lymphoma as a classical human model of multistage oncogenesis.
p53, a nuclear, DNA-binding phosphoprotein, is thought to play an important role in the negative regulation of cell growth (reviewed in Haner and Oren, 1995) and its alteration contributes to the deregulated growth of the majority of human cancers. Indeed, the p53 gene is mutated in a wide variety of human cancers with an overall frequency of 50% (Levine et al., 1991; Vogelstein and Kinzler, 1992) . Among hematological malignancies, p53 is most often mutated in BL cells. Mutations in the p53 gene have been found in at least 33% of BL biopsies (Gaidano et al., 1991; Bhatia et al., 1992) and as much as 83% of BL cell lines (Wiman et al., 1991; Farrell et al., 1991) . Furthermore, analysis of several of these BL p53 mutants showed that they were functionally altered (Farrell et al., 1991; Vousden et al., 1993) . It was therefore suggested that, in addition to the deregulation of c-myc, p53 inactivation also contributes to the malignant phenotype of BL cells (Gaidano et al., 1991; Imamura et al., 1994) .
Wild-type p53, which exhibits transcriptional regulatory activities, is involved in the cellular response to DNA damage, resulting in either G1 arrest (allowing repair of damaged DNA prior to DNA replication) (Dulic et al., 1994; el-Deiry et al., 1993) or apoptosis (Yonish-Rouaach et al., 1991; Ramqvist et al., 1993; Miyashita and Reed, 1995) . p53 has thus been described as a guardian of the genome (Lane, 1992) , limiting the development of genetic abnormalities arising in daughter cells by controlled replication of damaged DNA templates. In addition to mutations of the gene, the functional inactivation of p53 can also occur after interaction of the wild-type gene product with several viral (SV40 T Ag, Adenovirus E1B, Papilloma virus E6) or cellular proteins (MDM2).
The mdm2 (murine double minute 2) gene was originally identi®ed by virtue of its ampli®cation in a spontaneously transformed BALB/c 3T3 cell line containing double minutes (Fakharzadeh et al., 1991) . Subsequently, the possible involvement of the MDM2 protein in the development of human neoplasia was investigated, leading to the demonstration that, in several types of sarcomas, ampli®cation of its gene, resulted in an overexpression of the protein (Leach et al., 1993; Oliner et al., 1992) . On the other hand, it was shown that mdm2 gene expression is inducible by p53 (Barak et al., 1993) and that the MDM2 protein is able to inhibit the function of the p53 tumor suppressor by concealing its transactivation domain Momand et al., 1992) . More recently it was also shown that MDM2 promotes the rapid degradation of p53 (Kubbutat et al., 1997; Haupt et al., 1997) . Together, these molecules thus form an autoregulatory feedback loop critical for the control of cell growth (Wu et al., 1993) . Furthermore, it was shown that overexpression of the mdm2 gene can directly increase the tumorigenic potential of cells (Fakharzadeh et al., 1991) or their proliferation .
The aim of this work was to investigate the respective roles of p53 and MDM2 molecules in the regulation of BL cell proliferation. For that purpose, we examined MDM2 and p53 expression in 20 BL cell lines. As expected, most cell lines contained mutated p53 and did not express MDM2. In contrast, high amounts of MDM2 were detected in four cell lines that all contained wild-type p53. In these cells, MDM2 and p53 proteins were found to form stable complexes and p53 was unable to induce G1 arrest of apoptosis after g-radiation. We also found that the high level of the MDM2 protein in these BL cells, is not associated with an ampli®cation of the mdm2 gene nor with an elevated level of RNA or an increased protein stability. Rather, our results indicate that in BL cells containing wild-type p53, overexpression of MDM2 protein is most likely due to an enhanced translational activity.
Results

p53 protein expression and gene status
The expression of p53 protein was tested in BL cell lines by Western-blot analysis using DO1, an anti-p53 mAb. The results obtained with eight BL cell lines and JAR (a choriocarcinoma cell line, which was previously shown to carry wild-type p53 protein (Landers et al., 1994) ) are shown in Figure 1a : BL2, Seraphina, Ly47 and Ly91 contained small amounts of p53, BL7 a higher quantity whereas three other cell lines (BL10, Raji and BL63) exhibited a very high level of p53 protein. Twelve other BL cell lines were tested by immunoblotting with DO1 antibody: a very strong band was detected in eleven cell lines and a relatively faint band in one cell line (data not shown). As previously reported (Wiman et al., 1991) HL60 does not express p53 whereas the two LCL tested were found to contain a very small amount of p53 (data not shown).
Since wild-type p53 has a short half-life compared to mutant p53, it is generally assumed that a faint band detected in Western-blot corresponds to a wildtype p53. In order to directly determine the presence or absence of mutations in the p53 gene of our BL cell lines with low or intermediate levels of p53, the entire coding sequence (exons 2 ± 11) was analysed by single strand conformation polymorphism (SSCP) . No migration shift could be observed for Seraphina, Ly91, Ly47 and BL7 thus con®rming that these cell lines contained wild-type p53. A migration shift was observed for BL2. Direct sequencing of the PCR product con®rmed a previous report of a polymorphism at codon 72 (Farrell et al., 1991) . Therefore BL2 also contains wild-type p53 gene. Exons 5 ± 9 were analysed by SSCP for Raji, BL10, BL63 and 12 other BL cell lines. Abnormal migrating bands, suggestive of a mutated p53, were observed for all ± including Raji, BL10 and BL63 ± but one (data not shown).
Overexpression of MDM2 protein in BL cell lines containing wild-type p53 MDM2 expression was then tested in the same BL cell lines by Western-blot analysis using IF2, an anti-MDM2 mAb. JAR was again used as a positive control because of its previously reported overexpression of MDM2 protein (Landers et al., 1994) . Results obtained for the eight BL cell lines, which are presented in Figure 1a for p53 expression, are shown in Figure 1b : BL2, Seraphina, Ly47 and Ly91 cell lines, which contain wild-type p53, displayed a high level of MDM2 protein whereas BL7, which also carry wildtype p53, had an almost undetectable level of MDM2. No (for BL10 and BL63) or extremely low (for Raji) MDM2 protein level could be detected in the three other BL cell lines. In order to ascertain that MDM2 was truly overexpressed in BL2, Seraphina, Ly47 and Ly91 cells, we also tested the level of expression of this protein in normal tonsilar B lymphocytes. As shown in Figure 1b , no MDM2 protein could be found in these cells. To control the level of proteins in each sample, the blot was also probed with an anti-b-actin. Similar amounts of protein were detected for all samples (data not shown). The twelve other BL cell lines which were also tested by Western-blot, exhibited a minimal or no expression of MDM2 (data not shown). Therefore, Association between MDM2 and wild-type p53
In order to determine if the MDM2 molecules in these four BL cell lines (BL2, Seraphina, Ly47, Ly91) are associated with p53, cell extracts were immunoprecipitated with either an anti-MDM2 mAb (IF2) or an anti-p53 mAb (DO1) and the immunoprecipitated proteins were then submitted to Western-blotting using antibodies directed against these two proteins.
Results are shown in Figure 2 . In the four cell line samples, when immunoprecipitations were carried out with IF2, a strong band migrating at 95 kDa was detected by immunoblotting with IF2 (top panel for each cell line) and a fainter band was also detected at 53 kDa by immunoblotting with a polyclonal rabbit anti-p53 antibody (bottom panel for each cell line). In reverse, when DO1 was used as the precipitating antibody, a major band of 53 kDa was seen after electrophoresis and incubation of the immunoprecipitates with the anti-p53 antiserum (bottom panel), and a fainter band of 95 kDa was observed after incubation with IF2 (top panel). When an irrelevant mouse IgG was used as a negative control in the immunoprecipitation experiments, no protein was detected by Western blottings. This led us to conclude that MDM2 and wild-type p53 proteins are associated within these BL cells.
Inactivation of p53 in BL cell lines containing MDM2
Since the above co-immunoprecipitation experiments could suggest that not all p53 protein is complexed to MDM2, we decided to test the functional status of p53 in these four BL cell lines.
For that purpose, we tested the ability of the p53 protein to block the cells in the G1 phase or to induce apoptosis, following g-radiation.
Asynchronously growing BL2, Seraphina, Ly47 and Ly91 cells were exposed to 7 Gy of g-radiation and the fractions of cells in the various phases of the cell cycle were analysed 16 h after irradiation. Raji cells which contain mutant p53 and BL7 cells which have wildtype p53 without overexpression of MDM2 were used as controls. Furthermore normal mouse thymocytes, which were previously shown to be highly susceptible to p53-dependent apoptosis induced by g-radiation (Clarke et al., 1993) , were also included in this study.
The data presented in Figure 3 clearly show that the irradiated BL cell lines containing both p53 and MDM2 did not arrest in G1 phase nor enter apoptosis. Rather, they show a strong G2/M checkpoint arrest, typical of cells containing inactivated or null p53 as exampli®ed by the mutant p53 containing cells Raji. By contrast, g-radiation did not arrest BL7 cells in G1 nor in G2/M but rather induced apoptosis: the percentage of sub-diploid apoptotic cells (appearing to the left of the G1 peak) increased from 4% in the non-irradiated control cells to 25% in the irradiated cells. Similarly, and as expected, g-radiation induced apoptosis of the thymocytes since the percentage of sub-diploid cells increased from 17% before irradiation to 76% after irradiation. From these results, it can be concluded that, in BL cells overexpressing MDM2, the p53 pathways which lead to G1 arrest or apoptosis of the cells after irradiation are inactivated. In order to exclude that the p53 protein of these BL cells was inactive per se, we decided to use the p53 functional assay, developed by Flaman et al., which tests the transcriptional competence of the human p53 gene expressed in yeast. In this test, the yeast strain (yIG397) contains a plasmid with the ADE2 open reading frame under the control of a p53 responsive element. When this strain is transformed with a plasmid containing functional wild-type p53, the cells express ADE2 and grow as normal white colonies on medium containing limited amounts of adenine. By contrast, yeast cells transformed with mutated p53 do not express ADE2 and form only small red colonies (due to the accumulation of an intermediate in adenine metabolism). As shown in Table 1 , p53 cDNA from BL2, Seraphina, Ly47 and Ly91 gave between 2 and 12% of red colonies, which correspond to a typical background for wild-type p53 samples (Flaman et al., 1995) . Together with the results of the immunoprecipitation experiments and the data obtained on irradiated cells, these results strongly suggest that the function of the wild-type p53 gene product in these four BL cell lines is inactivated by MDM2. Figure 2 Co-precipitation of MDM2 and wild-type p53 in four BL cell lines. Superparamagnetic polystyrene beads coated with goat anti-mouse IgG were mixed with either anti-p53 mAb (DO1), anti-MDM2 mAb (IF2) or mouse IgG2b (control) and then incubated with the cellular lysates. The immunoprecipitated proteins were then submitted to Western-blot analysis. The blots were incubated with either rabbit anti-p53 Ab or anti-MDM2 mAb, followed by incubation with a horseradish peroxidase linked rabbit anti-mouse IgG or a horseradish peroxidase linked donkey anti-rabbit Ig. The blots were revealed by chemiluminescence
Analysis of mdm2 gene and mdm2 RNA
To investigate the molecular mechanism responsible for the elevated level of MDM2 protein in BL2, Seraphina, Ly47 and Ly91 BL cell lines, Southernblot analysis of the mdm2 gene was performed using DNA of JAR cells (which contains an ampli®ed mdm2 gene) as control (Landers et al., 1994) . No signi®cant gene ampli®cation could be detected in the BL cells (data not shown). Northern-blot analysis was also performed on various BL cell lines and on JAR cells. As shown in Figure 4 , a single mdm2 transcript of 5.5 kb (corresponding in size to that reported previously (Oliner et al., 1992) ) was observed in all BL cells, except BL63. The levels of mdm2 RNA expressed by Ly91, Ly47, BL2 and Seraphina were variable but consistently much lower than the mdm2 RNA level of the JAR cells. Surprisingly, Raji cells which were included as a negative control because they contain an extremely low level of MDM2 protein, exhibited an mdm2 RNA level comparable to Seraphina or Ly47 cells. These results indicate that, in the BL cell lines tested, the overexpression of MDM2 protein is not due to an ampli®cation of the mdm2 gene, nor to an elevated level of transcription.
Normal short half-life of MDM2 protein
The MDM2 protein has been previously described as a short lived species protein with a half-life of approximately 15 ± 30 min . Since the high level of MDM2 protein could also result from an extended half-life, we conducted pulse-chase experiments to determine the half-life of MDM2 in BL2, Seraphina, Ly47 and Ly91. The autoradiograms of the SDS-polyacrylamide gels upon which the immunoprecipitates were analysed are shown in Figure 5 . These SDS-polyacrylamide gels were also analysed with a Phosphoimager which allowed us to Figure 4 Northern-blot analysis of mdm2 RNA expression in BL cell lines. 20 mg of total cellular RNA from six BL cell lines and one choriocarcinoma cell line (JAR) were size fractionated on a formaldehyde-1,2% agarose gel, transferred to nitrocellulose membrane, and hybridized to a 32 P-labeled human mdm2 cDNA probe (pHDM) (top panel). To con®rm adequate loading of all lanes, the membrane was then rehybridized to a 18S probe (bottom panel) quantify the various bands (after substraction of the background of each lane) and then determine the halflife of MDM2. In the four BL cell lines tested, MDM2 protein exhibited the expected short half-life of 20 ± 30 min, therefore excluding perturbed half-life as a mechanism for accumulation of MDM2 protein.
Enhanced translation of mdm2
In a previous report, it was shown that enhanced translation capacity of the cells can cause MDM2 overexpression (Landers et al., 1994) . To analyse the translation of MDM2 in BL cells, we performed short metabolic labeling (15 min) followed by immunoprecipitation with IF2. In addition to the four BL cell lines (BL2, Seraphina, Ly47 and Ly91) which overexpress MDM2, a BL cell line (Raji) which contains comparable amount of mdm2 mRNA but does not overexpress the protein and the BL63 cell line which does not produce MDM2, were included in this experiment. As shown in Figure 6 , BL2, Seraphina, Ly47 and Ly91 produce much more MDM2 protein than the Raji cells (with Ly91 expressing less MDM2 than the three other cell lines). These results suggest enhanced translation of mdm2 RNA as the principal or the sole mechanism responsible for the accumulation of MDM2 in these four BL cell lines.
Discussion
The role of MDM2 protein in the transformation process has been previously demonstrated in several tumoral systems. In most cases, MDM2 has been described as an inhibitor of p53 function or, more recently, as a promoter of p53 degradation (reviewed in Piette et al., 1997) but it has also been reported that MDM2 can interact and hence inhibit the growth regulatory function of the pRB molecule (Xiao et al., 1995) . Two recent reports further underscore the critical physiological importance of MDM2: mice de®cient for MDM2 die early in development (soon after implantation of the embryo in the uterus) but this embryonic lethality is rescued in the absence of p53 (Montes de Oca Luna et al., 1995; Jones et al., 1995) . These results clearly indicate that the critical role of MDM2 during development is to negatively regulate p53 activity. They also reinforce the idea that loss of the normal function of these two molecules is crucial in certain oncogenesis processes. Since previous data suggested that inactivation of p53 could be an important and speci®c step in the pathogenesis of Burkitt's lymphomas (reviewed in Imamura et al., 1994) , we have studied the expression of p53 and MDM2 molecules in a panel of BL cell lines.
The results presented here show that, among twenty BL cell lines examined, four contained functional wildtype p53 protein and a high level of MDM2 protein.
We also report that, in these BL cells, p53 and MDM2 are physically associated since the two molecules coprecipitated. Most importantly, we show that these BL cells, like the BL cells which carry mutated p53, neither arrest in the G1 phase nor undergo apoptosis following g-radiation but rather show a strong G2/M arrest. It is now well established that a genotoxic stress induces accumulation of wild-type p53 protein which determines a transient arrest of the cells in the G1 phase of the cell cycle or triggers apoptosis (Levine, 1997) . By contrast, cells containing mutated or null p53 do not arrest in G1 but show a DNA damage-induced G2 arrest (Kuerbitz et al., 1992; Kastan et al., 1991) . We therefore concluded from our results that, in these four BL cell lines, p53 is most likely inactivated by complexation with MDM2.
A previous study (O'Connor et al., 1993) has shown that BL cells which contain mutated p53 do not arrest in G1 (as con®rmed here with the Raji cell line) but are strongly blocked in G2. Among our four BL cell lines containing p53 and MDM2, BL2 behaved exactly like Raji with more than 70% of the cells blocked in the G2 phase whereas only 39 ± 51% of the cells are arrested in G2 for the three other cell lines. These dierences in response to g-radiation are most probably the re¯ect of We have also investigated the mechanism underlying the overexpression of MDM2. Our data demonstrate that accumulation of MDM2 was not due to gene ampli®cation nor to elevated level of RNA or stabilization of the protein. In contrast, short metabolic labeling experiments indicated that these four BL cell lines produce more MDM2 protein than control cells. Taken together, our results point towards enhanced translation as the most likely mechanism to account for accumulation of MDM2.
Although gene ampli®cation most commonly accounts for MDM2 overexpression in tumoral cells (Leach et al., 1993; Reifenburger et al., 1993) , other mechanisms have also been described. In childhood acute lymphoblastic leukemia (ALL) cells, an elevated level of mdm2 RNA was reported in the absence of any gene ampli®cation (Zhou et al., 1995) . In a murine plasmacytoma cell line, a chromosomal translocation, resulting in a re-arrangement of the mdm2 gene with the immunoglobulin Ck gene, was shown to activate MDM2 expression, and in a human breast carcinoma, a correlation was demonstrated between the estrogen receptor status and the mdm2 mRNA levels (Berberich and Cole, 1994; Sheikh et al., 1993) . Recently, a posttranscriptional regulation of MDM2 expression by enhanced level of translation has been described in a choriocarcinoma cell line (Landers et al., 1994) , in various melanoma cell lines (Landers et al., 1997) and several cases of Sezary syndrome and ALL with normal levels of mdm2 RNA and overexpression of MDM2 protein have ben reported (Marks et al., 1996a, b) . With the present report of a translational control of gene expression, responsible for the accumulation of MDM2 protein, this mechanism appears to represent a second frequent mechanism, distinct from gene ampli®cation, to account for MDM2 accumulation. This emphasizes the importance of measuring the level of MDM2 protein (and not only mRNA level) in tumors containing wild-type p53.
The results presented herein certainly strengthen the hypothesis that inactivation of p53 could be an important and speci®c step in the pathogenesis of BL cells (Gaidano et al., 1991; Imamura et al., 1994) . Indeed, we show that fourteen out of the twenty BL cell lines tested most likely contain mutated p53 (as assessed by SSCP analysis) and four out of the twenty contain wild-type p53 inactivated by complexation with MDM2, which means that 90% of these cell lines most probably have non-functional p53. Several reports have underlined that in fresh BL samples, the incidence of p53 mutations, although relatively high, is lower than in BL cell lines (reviewed in Imamura et al., 1994) . Considering our results, it would probably be of great interest to examine the expression of MDM2 in fresh BL tumor cells containing wild-type p53 to really assess the functional status of p53 in these cells. Such data would allow, not only to clarify the biological role of p53 in BL cells but also could shed new light on the clinical signi®cance of p53 alterations in this tumor. Indeed, it has been reported that, in contrast to other hematologic malignancies (Wattel et al., 1994; Marks et al., 1997) , the presence of p53 mutations is not correlated with a worse prognosis in BL (Preudhomme et al., 1995) . However, since we have shown that, in a signi®cant percentage of BL cases, wild-type p53 can be inactivated by another way than gene mutation, it seems necessary to re-examine these data in considering both mutations of the p53 gene and MDM2 expression.
It was also previously suggested that, in BL cells, p53 inactivation could act synergistically with the cmyc proto-oncogene activation which always occurs in these cells (Gaidano et al., 1991; Imamura et al., 1994) . Several groups have recently studied the functional interaction between c-myc and p53 and various cooperative mechanisms were suggested. It was ®rst shown that c-myc-induced apoptosis is mediated by p53 and therefore suggested that p53 alterations could spare cells containing activated c-myc from apoptosis (Hermeking and Eick, 1994) . On the other hand, it was proposed that the synergistic eect of c-myc deregulation and p53 inactivation was not reduced apoptosis but rather enhanced proliferation (Hsu et al., 1995) . Finally, it was suggested that p53 loss contributes to immortalisation due to oncogenic changes, by abrogating an intrinsic senescence program (Metz et al., 1995) . The four BL cell lines analysed here with deregulated c-myc and wild-type p53 genes should prove valuable to gain further insight into these issues.
Materials and methods
Cells
Cell lines were cultured at 378C in complete medium (GIBCO-BRL, Scotland) containing 2 mM L-glutamine, 1 mM pyruvate, 20 mM glucose, 20 mg/ml gentamicine and supplemented with 5% heat-inactivated fetal calf serum (FCS). BL2, BL3, BL7, BL9, BL10, BL18, BL28, BL36, BL38, BL40, BL63, BL72, Ly47, Ly67, Ly91 and Chevalier were kindly given by Dr G Lenoir (Lyon, France); Raji, Ramos, Seraphina were a gift from Pr G Klein (Stockholm, Sweden) and IGR BL1 was established at Institut Gustave Roussy (Villejuif, France). Four other cell lines were used as control: IARC80 and Remb1 (two lymphoblastoid cell lines (LCL)), HL-60 (a promyelocytic leukemic cell line) and JAR (a choriocarcinoma cell line).
Tonsilar lymphocyte suspensions were prepared by gentle teasing of tonsils in complete RPMI 1640 medium. B lymphocytes were then obtained after depletion of T cells by rosetting out sheep erythrocyte receptor-positive cells with 2-aminoethylisothiouronium bromide-treated sheep erythrocytes and Ficoll-Hypaque gradient separation. Thymocytes were obtained after dissociation of the thymus from 1 ± 2 week-old BALB/c mice in complete RMPI 1640 medium.
Western blot analysis
Cell pellets, resuspended in lysis buer (50 mM Tris-HCl pH 6.8, 2% SDS, 100 mM DTT, 1 mM aprotinin), were sonicated for 15 s and then incubated for 10 min at 48C. Protein concentration in lysates was determined by using the Bio-Rad protein assay reagent. Equal quantities of proteins were loaded and separated on a SDS-7.5% polyacrylamide gel after dilution in loading buer (50 mM Tris-HCl pH 7.4, 2% SDS, 9% glycerol, 0.7 M b mercaptoethanol, 0.005% bromophenol blue). After electrophoresis, proteins were electroblotted to PVDF membranes (Millipore, USA) by semi-dry transfer (Millipore, USA). After blocking with PBS containing 3% non-fat dry milk and 2% glycine, blots were probed with either an anti-MDM2 mAb IF2 (Oncogene Science, USA) or an anti-p53 mAb DO1 (Santa Cruz, USA) or a rabbit anti-p53 Ab (FL-393, Santa Cruz, USA) at the concentration of 2 mg/ml. After incubation with a goat anti-mouse IgG (GAM, ICN, UK), the blots were revealed with [ 125 I]protein A (Amersham, UK) and submitted to autoradiography. Alternatively, after incubation with a horseradish peroxidase linked rabbit anti-mouse IgG (Zymed, USA), or a horseradish peroxidase linked donkey anti-rabbit Ig (Amersham; UK) the blots were revealed by enhanced chemiluminescence (ECL, Amersham, UK).
SSCP analysis of p53
Ampli®cations were performed with 320 ng of genomic DNA extracted from the four cell lines (BL2, Ly47, Ly91 and Seraphina), 3 pmol of each primer, 5 mM dNTPs, 2 mCi of [a-
33 P]dATP, 1.25 mM MgCl 2 , PCR II buer (Pharmacia) in a ®nal volume of 20 ml. The primers which were previously described (Lazar et al., 1994) allow the study of the entire coding region of p53 (exons 2 ± 11 of the p53 gene). Taq polymerase (0.5 units) was then added to the mixture and DNA ampli®cation was carried out in a Thermal Cycler (Perkin-Elmer 9600) by 30 cycles of PCR (30 s at 958C, 30 s at 588C and 30 s at 728C). Ampli®ed samples were then denatured and loaded onto a nondenaturing Hydrolink MDE gel containing 7.5% glycerol and run at room temperature for 18 h at 8 W. Another gel without glycerol was run at 48C. Gels were dried at 808C under vacuum and exposed to X-ray ®lm at room temperature.
Functional p53 assay
Total cellular RNA was extracted from cell lines by guanidine thiocyanate/cesium chloride method followed by ethanol precipitation. cDNA was synthesized, at 378C for 55 min, by 50 units of Superscript II from 2 mg of RNA in a ®nal volume of 50 ml of RT buer containing 1.5 ml of random primer. PCR was performed by Pfu polymerase and phosphorothioate-modi®ed primers P3 and P4 as previously described (Flaman et al., 1995) . 5 ml of the PCR product was then used for the yeast transformation assay using the yIG397 strain (Flaman et al., 1995) . Red colonies were scored after 2 ± 3 days at 358C.
Cell cycle analysis
Exponentially growing cells (3.5610 5 cells/ml) were irradiated at room temperature (7 Gy) using a 137 Cs source delivering 1.57 Gy/min. Cells were then incubated at 378C and cell cycle distribution was quantitated 16 h following g-radiation. Cells were ®xed in 70% ethanol at 48C for 2 h, centrifuged and then resuspended in PBS, treated with RNase (30 min at 378C, 2 U/ml, Sigma, France). DNA was stained with propidium iodide (2 mg/ml) and cell cycle determination was performed using a FACSCalibur (Becton Dickinson, USA) analyser using manual gating. Debris were excluded on the basis of their forward and side light-scattering properties.
Northern-blot analysis
Total cellular RNA was extracted from cell lines by guanidine thiocyanate/cesium chloride method followed by ethanol precipitation. 20 mg of each RNA sample were loaded and separated in formaldehyde-1.2% agarose gels and then transferred to nitrocellulose membranes (Hybond TM -C, Amersham) in SSPE 206 buer. The blots were prehybridized at 428C, overnight, in a buer containing 50% formamide, SSPE 56, 0.1 SDS, 56Denhardt and 100 mg/ml ssDNA. Hybridization was then realized with [ 32 P]random priming probes (pHDM plasmid containing mdm2 cDNA (a kind gift of Dr A Levine) and a 18S probe used as a control). After washings in SSPE 26, 0.1% SDS at 608C, and then in SSPE 0.56, 0.1% SDS at 808C, ®lters were submitted to autoradiography.
Immunoprecipitation
Cells pellets were resuspended in lysis buer (10 mM TrisHCl pH 7.4, 150 mM NaCl, Pefabloc, 1% Triton) and kept for 30 min at 48C. Superparamagnetic polystyrene beads (Dynabeads M-450, Dynal, France) coated with goat antimouse IgG were used for immunoprecipitation. These beads were mixed with 1 mg of antibodies (anti-MDM2 mAb IF2 or anti-p53 mAb DO1 or IgG2b (Pharmingen, USA) used as a control) in PBS containing 0.1% BSA and incubated 45 min at room temperature. After washings, the cell lysates were incubated overnight at 48C with the coated beads. The immunoprecipitates were then washed ten times with lysis buer prior to boiling in loading buer for 4 min. Immunoprecipitated proteins were then separated on 7.5% SDS-polyacrylamide gels. After electrophoresis, proteins were electroblotted to PVDF membranes by liquid transfer (Biorad, USA) and analysed by Western-blotting as described above.
MDM2 half-life and translation analysis
For half-life determinations, cells were cultured in cysteindeprived media for 30 min followed by incubation with [ 35 S]cystein (Amersham, UK) (100 mCi/ml) for 3 h at 378C and then chased for various periods of time (up to 240 min) in non-radioactive RPMI 1640 supplemented with 5% FCS. Lysis buer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% NP-40, 5 mM EDTA, Pefabloc, 2.5 mg/ml aprotinin, 2 mg/ml leupeptin) was then added to the cells which were kept for 30 min at 48C. Lysates were precleared with Protein A-sepharose and precipitable material were incubated with 1 mg of anti-MDM2 mAb IF2 or anti-p53 mAb DO1 or anti-HTLV1 mAb (used as a control) and 20 ml of 50% protein A-Sepharose. The immunoprecipitates were washed three times with SNNTE buer (5% sucrose, 1% NP-40, 500 mM NaCl, 50 mM TrisHCl pH 7.5, 5 mM EDTA) and three other times with RIPA buer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% SDS, 0.5% NP-40, Pefabloc, 1% sodium deoxycholate) prior to boiling in loading buer for 3 min. Immunoprecipitated proteins were separated on 7.5% SDS-polyacrylamide gels and gels were then ®xed in isopropanol-wateracetic acid solution. Radioactivity intensity was ampli®ed with an Amplify solution (Amersham, UK) before autoradiography. Quantitation of each band corresponding to MDM2 protein was performed with the Phosphoimager (Fuji, France). Half-live were determined by regression analysis performed with Cricket Graph Software on a Macintosh computer. The half-life was determined to be the time point at which 50% of the zero-time counts remained. For MDM2 translation analysis, cells were labeled for 15 min with 500 mCi/ml of [ 35 S]cystein, harvested and then subjected to the same experiment steps as above.
